Roger Murphy
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Molecular Medicine top 10%
Papers in
-
- Receptor Mechanisms and Signaling 8
- Nicotinic Acetylcholine Receptors Study 5
- Glycosylation and Glycoproteins Research 3
- Chemical Synthesis and Analysis 3
-
- Immunotherapy and Immune Responses 6
- Immune Cell Function and Interaction 2
- Co-authors
- James A. Angus (6 shared papers)Michael J. Lew (5 shared papers)Andrew M. Scott (9 shared papers)Lloyd J. Old (8 shared papers)Paul K. Pallaghy (3 shared papers)Raymond S. Norton (3 shared papers)Hiroshi Shiku (7 shared papers)Eric W. Hoffman (7 shared papers)
- Journals
- Clinical Cancer Research (3 papers)Histochemistry and Cell Biology (2 papers)European Journal of Biochemistry (2 papers)International Journal of Cancer (2 papers)Journal of Nuclear Medicine (1 paper)
- Partner nations
- AustraliaUnited StatesJapan
In The Last Decade
Roger Murphy
25 papers receiving 909 citations
Peers
Comparison fields: 5 of 91
- Immunology 249
- Molecular Medicine 51
- Pharmaceutical Science 51
- Oncology 204
- Molecular Biology 548
Countries citing papers authored by Roger Murphy
This map shows the geographic impact of Roger Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Murphy more than expected).
Fields of papers citing papers by Roger Murphy
This network shows the impact of papers produced by Roger Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Murphy. The network helps show where Roger Murphy may publish in the future.
Co-authors
The 25 scholars most cited alongside Roger Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 112 | |
| 2 | 2008 | 107 | |
| 3 | 2000 | 97 | |
| 4 | 1997 | 92 | |
| 5 | 2007 | 64 | |
| 6 | 2007 | 61 | |
| 7 | 1999 | 50 | |
| 8 | 1996 | 47 | |
| 9 | 2006 | 40 | |
| 10 | 2008 | 37 | |
| 11 | 2008 | 36 | |
| 12 | 1996 | 34 | |
| 13 | 1999 | 29 | |
| 14 | 2014 | 27 | |
| 15 | 1996 | 26 | |
| 16 | 2012 | 25 | |
| 17 | 2003 | 20 | |
| 18 | The impact of graded tests | 1988 | 14 |
| 19 | 1995 | 10 | |
| 20 | 1995 | 7 |
About Roger Murphy
Roger Murphy is a scholar working on Molecular Biology, Immunology, Cellular and Molecular Neuroscience, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 26 papers that have together received 951 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (8 papers), Immunotherapy and Immune Responses (6 papers), Nicotinic Acetylcholine Receptors Study (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Neuropeptides and Animal Physiology (4 papers), Glycosylation and Glycoproteins Research (3 papers), Chemical Synthesis and Analysis (3 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Immunology (249 citations), Molecular Medicine (51 citations), Pharmaceutical Science (51 citations), Oncology (204 citations) and Molecular Biology (548 citations). Roger Murphy has collaborated with scholars based in Australia, United States and Japan. Frequent co-authors include James A. Angus, Michael J. Lew, Andrew M. Scott, Lloyd J. Old, Paul K. Pallaghy, Raymond S. Norton, Hiroshi Shiku, Eric W. Hoffman, Yasuhiro Nagata and Shigehisa Kitano. Their work appears in journals such as Clinical Cancer Research, Histochemistry and Cell Biology, European Journal of Biochemistry, International Journal of Cancer and Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.